Natural killer cell-mediated cytokine response among HIV-positive south indians with pulmonary tuberculosis

Journal of Interferon and Cytokine Research

Volumn 30, Issue 1, 2010, Pages 33-41

  Ramana Rao, P V ^a   Rajasekaran, S ^b   Raja, Alamelu ^a  

^a NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS   (India)

^b Government Hospital of Thoracic Medicine   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELL COUNT; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSTIMULATION; INDIAN; INNATE IMMUNITY; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; NATURAL KILLER CELL; PRIORITY JOURNAL; STAINING;

ADOLESCENT; ADULT; CYTOKINES; FEMALE; HIV; HIV INFECTIONS; HUMANS; INDIA; KILLER CELLS, NATURAL; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; TH1 CELLS; TH2 CELLS; TUBERCULOSIS, PULMONARY;

MYCOBACTERIUM TUBERCULOSIS;

EID: 75149154644     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2009.0018     Document Type: Article

References (31)

1. Bal AM, Lakhashe SK, Thakar MR, Tripathy SP, Paranjape RS. 2005. Dysregulation of proinflammatory and regulatory cytokines in HIV infected persons with active tuberculosis. Cytokine 30(5):275-281.
2. Bancroft GJ. 1993. The role of natural killer cells in innate resistance to infection. Curr Opin Immunol 5(4):503-510.
3. Barnes PF, Lu S, Abrams JS, Wang E, Yamamura M, Modlin RL. 1993. Cytokine production at the site of disease in human tuberculosis. Infect Immun 61(8):3482-3489. (Pubitemid 23223442)
4. Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP. 1999. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol 17:189-220.
5. Brill KJ, Li Q, Larkin R, Canaday DH, Kaplan DR, Boom WH, Silver RF. 2001. Human natural killer cells mediate killing of intracellular Mycobacterium tuberculosis H37Rv via granule-independent mechanisms. Infect Immun 69(3):1755-1765.
6. Carson WE, Giri JG, Lindemann MJ, Linett ML, Ahdieh M, Paxton R, Anderson D, Eisenmann J, Grabstein K, Caligiuri MA. 1994. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med 180(4):1395-1403.
7. Carson WE, Ross ME, Baiocchi RA, Marien MJ, Boiani N, Grabstein K, Caligiuri MA. 1995. Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro. J Clin Invest 96(6):2578-2582.
8. Chehimi J, Marshall JD, Salvucci O, Frank I, Chehimi S, Kawecki S, Bacheller D, Rifat S, Chouaib S. 1997. IL-15 enhances immune functions during HIV infection. J Immunol 158(12):5978-5987.
9. Collins KR, Quinones-Mateu ME, Toossi Z, Arts EJ. 2002. Impact of tuberculosis on HIV-1 replication, diversity, and disease progression. AIDS Rev 4(3):165-176.
10. d'Ettorre G, Forcina G, Lichtner M, Mengoni F, D'Agostino C, Massetti AP, Mastroianni CM, Vullo V. 2002. Interleukin-15 in HIV infection: immunological and virological interactions in antiretroviral-naive and -treated patients. AIDS 16(2):181-188.
11. Denis M. 1994. Interleukin-12 (IL-12) augments cytolytic activity of natural killer cells toward Mycobacterium tuberculosis-infected human monocytes. Cell Immunol 156(2):529-536.
12. Fehniger TA, Shah MH, Turner MJ, VanDeusen JB, Whitman SP, Cooper MA, Suzuki K, Wechser M, Goodsaid F, Caligiuri MA. 1999. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response. J Immunol 162(8):4511-4520.
13. Gerosa F, Baldani-Guerra B, Nisii C, Marchesini V, Carra G, Trinchieri G. 2002. Reciprocal activating interaction between natural killer cells and dendritic cells. J Exp Med 195(3):327-333.
14. Hirsch CS, Hussain R, Toossi Z, Dawood G, Shahid F, Ellner JJ. 1996. Cross-modulation by transforming growth factor beta in human tuberculosis: suppression of antigen-driven blastogenesis and interferon gamma production. Proc Natl Acad Sci USA 93(8):3193-3198.
15. Hirsch CS, Ellner JJ, Blinkhorn R, Toossi Z. 1997. In vitro restoration of T cell responses in tuberculosis and augmentation of monocyte effector function against Mycobacterium tuberculosis by natural inhibitors of transforming growth factor beta. Proc Natl Acad Sci USA 94(8):3926-3931.
16. Kitaura H, Ohara N, Kobayashi K, Yamada T. 2001. TNF-alphamediated activation of HIV-1 LTR in monocytoid cells by mycobacteria. FEMS Immunol Med Microbiol 31(2):97-103.
17. Lin SJ, Roberts RL, Ank BJ, Nguyen QH, Thomas EK, Stiehm ER. 1997. Human immunodefi ciency virus (HIV) type-1 GP120- Specific cell-mediated cytotoxicity (CMC) and natural killer (NK) activity in HIV-infected (HIV+) subjects: enhancement with interleukin-2(IL-2), IL-12, and IL-15. Clin Immunol Immunopathol 82(2):163-173.
18. Lorgat F, Keraan MM, Ress SR. 1992a. Cellular immunity in tuberculous pleural effusions: evidence of spontaneous lymphocyte proliferation and antigen-Specific accelerated responses to purifi ed protein derivative (PPD). Clin Exp Immunol 90(2):215-218.
19. Lorgat F, Keraan MM, Ress SR. 1992b. Compartmentalization of the cellular immune response to the recombinant 65 kDa protein of Mycobacterium bovis BCG in patients with tuberculous pleuritis. Reg Immunol 4(1):12-17.
20. Mosier DE. 2000. Virus and target cell evolution in human immunodefi ciency virus type 1 infection. Immunol Res 21(2-3):253-258.
21. Okamura H, Kashiwamura S, Tsutsui H, Yoshimoto T, Nakanishi K. 1998. Regulation of interferon-gamma production by IL-12 and IL-18. Curr Opin Immunol 10(3):259-264.
22. Perussia B. 1991. Lymphokine-activated killer cells, natural killer cells and cytokines. Curr Opin Immunol 3(1):49-55.
23. Ramachandran R, Datta M, Subramani R, Baskaran G, Paramasivan CN, Swaminathan S. 2003. Seroprevalence of human immunodefi ciency virus (HIV) infection among tuberculosis patients in Tamil Nadu. Indian J Med Res 118:147-151.
24. Ramana Rao PV, Rajasekaran S, Raja A. 2008. Augmentation of natural killer activity with exogenous interleukins in patients with HIV and pulmonary tuberculosis coinfection. AIDS Res Hum Retroviruses 24(11):1435-1443.
25. Revised National Tuberculosis Control Programme. 2005. Technical and operational guidelines for Tuberculosis Control. Central TB Division, Directorate General of Health Services, Ministry of Health and Family Welfare, New Delhi, India. http://www. tbcindia.org/pdfs/ Technical%20&%20Operational%20guidelines% 20for%20TB%20Control.pdf.
26. Robertson MJ, Ritz J. 1990. Biology and clinical relevance of human natural killer cells. Blood 76(12):2421-2438.
27. Schluger NW, Perez D, Liu YM. 2002. Reconstitution of immune responses to tuberculosis in patients with HIV infection who receive antiretroviral therapy. Chest 122(2):597-602.
28. Steinbrook R. 2007. Tuberculosis and HIV in India. N Engl J Med 356(12):1198-1199.
29. Vankayalapati R, Wizel B, Weis SE, Samten B, Girard WM, Barnes PF. 2000. Production of interleukin-18 in human tuberculosis. J Infect Dis 182(1):234-239.
30. WHO. 2005. TB Global facts. http://www.tbalert.org/news-press/ documents/whotbfactsheet.pdf.
31. Zhang M, Gong J, Iyer DV, Jones BE, Modlin RL, Barnes PF. 1994. T cell cytokine responses in persons with tuberculosis and human immunodefi ciency virus infection. J Clin Invest 94(6):2435-2442.